The Role of Androgens in Female Sexual Dysfunction

Mayo Clinic Proceedings

Volumn 79, Issue 4 SUPPL., 2004, Pages

  Shifren, Jan L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTERIFIED ESTROGEN; ESTRADIOL; ESTRATEST; ESTROGEN; ESTROGEN DERIVATIVE; METHYLTESTOSTERONE; ORAL CONTRACEPTIVE AGENT; PRASTERONE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ACNE; ADRENAL INSUFFICIENCY; AGING; ANDROGEN THERAPY; ANXIETY DISORDER; CLINICAL TRIAL; CONFLICT; DEPRESSION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FATIGUE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; LIBIDO DISORDER; LIPID BLOOD LEVEL; LIVER DYSFUNCTION; OVARIECTOMY; REVIEW; SEXUALITY; SIDE EFFECT; STRESS; UROGENITAL TRACT DISEASE; VIRILIZATION; VOICE;

EID: 1642482603     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(19)30668-8     Document Type: Review

References (26)

1. Roberts LW, Fromm LM, Bartlik BD. Sexuality of women through the life phases. In: Wallis LA, ed. Textbook of Women's Health. Philadelphia, Pa: Lippincott-Raven; 1998:763-780.
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published correction appears in JAMA. 1999;281:1174]. JAMA. 1999;281:537-544.
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published correction appears in JAMA. 1999;281:1174]. JAMA. 1999;281:537-544.
4. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
5. Shifren JL. Androgen deficiency in the oophorectomized woman. Fertil Steril. 2002;77(suppl 4):S60-S62.
6. Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab. 2001;86:561-567.
7. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21:103-113.
8. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995;80:1429-1430.
9. Gower BA, Nyman L. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women. J Clin Endocrinol Metab. 2000;85:4476-4480.
10. Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118:793-798.
11. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol. 1993;14:283-293.
12. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987;49:397-409.
13. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med. 1985;47:339-351.
14. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 1995;21:227-236.
15. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril. 2003;79:1341-1352.
16. Arlt W, Justl HG, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab. 1998;83:1928-1934.
17. Lovas K, Gebre-Medhin G, Trovik TS, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab. 2003;88:1112-1118.
18. Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab. 2000;85:4650-4656.
19. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published correction appears in J Clin Endocrinol Metab. 1995;80:2799]. J Clin Endocrinol Metab. 1994;78:1360-1367.
20. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published correction appears in J Clin Endocrinol Metab. 1995;80:2799]. J Clin Endocrinol Metab. 1994;78:1360-1367.
21. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682-688.
22. Braunstein G, Shifren J, Simon J, Lucas J, Rodenberg C, Watts N. Testosterone patches for the treatment of low sexual desire in surgically menopausal women [abstract]. Menopause. 2003;10:587. Abstract P-70.
23. Davis S, Rees M, Ribot C, Moufarege A, Rodenberg C, Purdie D. Efficacy and safety of testosterone patches for the treatment of low sexual desire in surgically menopausal women [abstract]. Fertil Steril. 2003;80(suppl 3):S76. Abstract O-199.
24. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341:1013-1020.
25. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 2003;10:390-398.
26. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products [letter]. JAMA. 1998;280:1565.